| 5-R21-EB030071-04 |
Cherenkov luminescence mediated excitation of discrete lanthanide optical probes |
Eszter Boros |
University of Wisconsin-Madison |
| 5-R01-EB028858-04 |
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC |
Andrew Tsourkas |
University of Pennsylvania |
| 5-R01-EB021155-08 |
Copper-mediated Radiofluorination: from Proof-of-Concept to Clinical Impact |
Peter Scott |
University of Michigan at Ann Arbor |
| 1-DP2-EB037187-01 |
Deep-tissue targeted molecular imaging with a palette of NIR-II emissive DNA-stabilized nanoclusters |
Stacy Copp |
University of California-Irvine |
| 5-R01-EB029429-04 |
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications |
Michael Evans |
University of California, San Francisco |
| 5-R01-EB029756-04 |
Developing Multimodal Multiplexed ImmunoPET-Raman Probes to Guide Immunotherapies |
Rizia Bardhan |
Iowa State University |
| 5-R03-EB033633-02 |
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization |
Jingjie Hu |
North Carolina State University Raleigh |
| 5-R21-EB032025-03 |
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2) |
Xuyi Yue |
Nemours Children'S Hospital, Delaware |
| 5-R01-EB031519-02 |
Development of 18F PET radiotracers for M2 microglia as diagnostics for multiplesclerosis pathogenesis |
Paul Stupple |
Monash University |
| 5-R01-EB034731-02 |
Development of an apoptosis biosensor for monitoring of breast cancer |
Lacey Mcnally |
University of Oklahoma Hlth Sciences Ctr |
